Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG. - Test2 - elhamkhani - TriplyDB

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.

http://www.wikidata.org/entity/Q37623149

about

Pathogenesis, humoral immune responses and transmission between co-housed animals in a ferret model of human RSV infection.The current landscape of nucleic acid tests for filovirus detection.

P2860

Q47571454-05DF6C9C-5B74-4F78-A20B-7E256F3926FA Q52602138-3261D3DF-5353-4850-A0D6-B4B0EEE9C107

P2860

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.

http://www.wikidata.org/entity/Q37623149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Successful post-exposure proph ...... coprotein-specific equine IgG.

@en

Successful post-exposure proph ...... coprotein-specific equine IgG.

@nl

type

label

Successful post-exposure proph ...... coprotein-specific equine IgG.

@en

Successful post-exposure proph ...... coprotein-specific equine IgG.

@nl

prefLabel

Successful post-exposure proph ...... coprotein-specific equine IgG.

@en

Successful post-exposure proph ...... coprotein-specific equine IgG.

@nl

P1433

Q37623149-8E02ADA6-AD69-44E2-AD0E-DDDAE61D3C29

P1476

Q37623149-A0D5A3BA-354D-42E4-8B3F-CF64E835DF7B

P2093

Q37623149-0815B8C9-A458-464D-B365-35421795FC67

Q37623149-1347F64A-37A9-4472-BCA1-4C782402AFE4

Q37623149-1E203D83-3F5F-4062-8B25-D9A5DEE951E9

Q37623149-2462F0B0-744A-4697-BC8D-30EC552D2C76

Q37623149-315CFB5B-3EF1-4A15-A522-3399117D0B67

Q37623149-40082351-8A85-46FF-BD8F-CC3C81C1C5E2

Q37623149-6FEBC2C7-C706-465C-A6EA-41E6817EA65D

Q37623149-7C523677-9EE8-4E93-A0DC-C9D1EC59B313

Q37623149-A6636CDD-C3D6-477A-91E6-02E97AF86A5C

Q37623149-B1567892-647E-4CAE-BE58-24499EBD4477

P2860

Q37623149-171A354D-B9D0-4D3F-B029-57FBE59AF282

Q37623149-1BE03E47-6EF9-4842-8831-4511B2967D5E

Q37623149-21AEE513-33E5-4A7A-A7A3-1C0EFF61ABAA

Q37623149-241CFCEA-CC27-4290-A26C-1A62BB5DD278

Q37623149-2CA3FD96-C21E-4618-B6A5-6C550587F8B5

Q37623149-2F408AA7-C053-4269-A3D4-7CA1D32357D9

Q37623149-3081F898-38E8-445C-9C48-4D75B49AA71B

Q37623149-3608DD64-FA41-47ED-8F28-508353B8DC21

Q37623149-38F474F5-118C-42E1-BB1D-30DC31057980

Q37623149-3D184D5E-7522-4822-8F06-5BA310CB70A2

P2888

Q37623149-C2B251E2-67A6-40DF-8F63-12A19DCE6D41

P304

Q37623149-1CDEEF27-1B7E-4403-B14E-B3AFF19D63DC

P31

Q37623149-4702B1CD-72AC-4F28-B399-018DF1580919

P356

Q37623149-02B9B6F4-22EB-4D42-A835-1ED4600A9531

P407

Q37623149-3514ABF3-C612-43F8-9A02-9C1331A4BA49

P478

Q37623149-6DE87CE9-F808-4EEF-8B66-D0560BC2305C

P50

Q37623149-1F1E4276-3E8D-425C-8603-62C0653424E6

Q37623149-656CE67B-68DA-4740-83D4-51CDA656853D

Q37623149-69943F8F-53A2-40E9-8931-76E74D04A986

Q37623149-6CAA2637-90F7-4DE8-AC6A-B6AB7D3053E3

Q37623149-968F285E-E187-4350-AFB3-15D5F9AB0209

P577

Q37623149-520BE031-5832-4525-AE77-6266E1B04EDC

P6179

Q37623149-0CC41186-5FCC-430C-BA36-537FB73D1E7B

P698

Q37623149-3C49712C-9672-45E2-AAD4-58D829EF455D

P921

Q37623149-4257E6B4-0FD9-47F7-B61A-5A72A724B995

P932

Q37623149-E0EDA7DC-1265-4BFD-A6DA-3856BA3C20AE

P356

P1433

Scientific Reports

P1476

Successful post-exposure proph ...... coprotein-specific equine IgG.

@en

P2093

Alexander A Agafonov

http://www.w3.org/2001/XMLSchema#string

Gabor Pali

http://www.w3.org/2001/XMLSchema#string

George Lovrecz

http://www.w3.org/2001/XMLSchema#string

Glenn Marsh

http://www.w3.org/2001/XMLSchema#string

Jillann F Farmer

http://www.w3.org/2001/XMLSchema#string

Judith H Edmonds

http://www.w3.org/2001/XMLSchema#string

Louis Lu

http://www.w3.org/2001/XMLSchema#string

Mylinh La

http://www.w3.org/2001/XMLSchema#string

Oleg V Pyankov

http://www.w3.org/2001/XMLSchema#string

Olga G Pyankova

http://www.w3.org/2001/XMLSchema#string

P2860

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb

Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

Development of a preventive vaccine for Ebola virus infection in primates

Antiviral therapeutics for the treatment of Ebola virus infection.

Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.

Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.

Shed GP of Ebola virus triggers immune activation and increased vascular permeability

P2888

P304

41537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP41537

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Alexander A. Khromykh

Yin Xiang Setoh

Andreas Suhrbier

Daniel Watterson

P577

2017-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083524756

http://www.w3.org/2001/XMLSchema#string

P698

28155869

http://www.w3.org/2001/XMLSchema#string

P921

P932

5290740

http://www.w3.org/2001/XMLSchema#string